Half-year report · Q2
8938.TEDINET S100USCS
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥484m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥12m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥96m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥8m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥192m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥124m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥112m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥0 | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥198m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥0 | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥8.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥644m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥593m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.8bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥304m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥187m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥44m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥335m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥38m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥65m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥49m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥45m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥45m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-0.07 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.91 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.99 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.0% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥186m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥180m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥18m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥199m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥199m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥192m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥418m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥418m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥75m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥20m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥484m |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥484m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥95m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥95m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 529
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 111000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 17000000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 42000000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 53000000 | JPY |
| Salaries sga | Prior1YTDDuration | 148000000 | JPY |
| Salaries sga | CurrentYTDDuration | 180000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | -13000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 1000000 | JPY |
| Share based compensation expenses sga | Prior1YTDDuration | 19000000 | JPY |
| Share based compensation expenses sga | CurrentYTDDuration | - | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 2000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 2000000 | JPY |
| Welfare expenses sga | Prior1YTDDuration | 32000000 | JPY |
| Welfare expenses sga | CurrentYTDDuration | 40000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 6000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 8000000 | JPY |
| Goodwill amortization sga | Prior1YTDDuration | - | JPY |
| Goodwill amortization sga | CurrentYTDDuration | 8000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember | 418000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember | 66000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 484000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 484000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 484000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember | 418000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember | 66000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 484000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 484000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales | Prior1YTDDuration | 484000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember | 75000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember | 20000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 95000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 95000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -192000000 | JPY |
| Operating income | Prior1YTDDuration | -96000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember | 1007000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember | 66000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 1074000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1074000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 1074000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |